Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection

Cellular Immunology

Volumn 274, Issue 1-2, 2012, Pages 12-18

  Zhu, Heng cheng ^a   Qiu, Tao ^a   Liu, Xiu heng ^a   Dong, Wang chao ^b   Weng, Xiao dong ^a   Hu, Chun hai ^a   Kuang, You lin ^a   Gao, Rui hui ^a   Dan, Chao ^a   Tao, Tao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Department of Surgery   (China)

Author keywords

Heart transplantation; Regulatory T cell; Rejection; Tolerogenic dendritic cell

Indexed keywords

SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELB;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOLEROGENIC DENDRITIC CELL;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CYTOKINES; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTOR RELB;

MURINAE;

EID: 84859901929     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.02.012     Document Type: Article

References (37)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007, 7:610-621.
3. Ehser .S., Chuang J.J., Kleist C., Sandra-Petrescu F., Iancu M., Wang D., et al. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties. Hum. Immunol. 2008, 69:165-173.
4. Lu L., Li W., Zhong C., Qian S., Fung J.J., Thomson A.W., et al. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 1999, 68:747-757.
5. Nouri-Shirazi M., Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation 2002, 74:1035-1044.
6. Buonocore S., Flamand V., Goldman M., Braun M.Y. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 2003, 75:407-413.
7. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 2002, 168:171-178.
8. Suciu-Foca N., Berloco P., Cortesini R. Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases. Hum. Immunol. 2009, 70:277-280.
9. Xu D.L., Liu Y., Tan J.M., Li B., Zhong C.P., Zhang X.H., et al. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scand. J. Immunol. 2004, 59:536-544.
10. Wang Q., Zhang M., Ding G., Liu Y., Sun Y., Wang J., et al. Anti-ICAM-1 antibody and CTLA-4Ig synergistically enhance immature dendritic cells to induce donor-specific immune tolerance in vivo. Immunol. Lett. 2003, 90:33-42.
11. Sun W., Wang Q., Zhang L., Liu Y., Zhang M., Wang C., et al. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin. Transplantation 2003, 76:1351-1359.
12. Carreno L.J., Riedel C.A., Kalergis A.M. Induction of tolerogenic dendritic cells by NF-kappaB blockade and Fcgamma receptor modulation. Methods Mol. Biol. 2011, 677:339-353.
13. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
14. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
15. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001, 13:675-683.
16. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536.
17. Pettit A.R., MacDonald K.P., O'Sullivan B., Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 2000, 43:791-800.
18. O'Sullivan B.J., MacDonald K.P., Pettit A.R., Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc. Natl. Acad. Sci. USA 2000, 97:11421-11426.
19. Clark G.J., Gunningham S., Troy A., Vuckovic S., Hart D.N. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999, 98:189-196.
20. Wu L., D'Amico A., Winkel K.D., Suter M., Lo D., Shortman K. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+dendritic cells. Immunity 1998, 9:839-847.
21. Martin E., O'Sullivan B., Low P., Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003, 18:155-167.
22. Platzer B., Jorgl A., Taschner S., Hocher B., Strobl H. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 2004, 104:3655-3663.
23. Wiethe C., Dittmar K., Doan T., Lindenmaier W., Tindle R. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. J. Immunol. 2003, 170:2912-2922.
24. Wang Y., Qin Q., Chen J., Kuang X., Xia J., Xie B., et al. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Transpl. Immunol. 2009, 22:5-11.
25. Heng-cheng Zhu T.T., Liu Xiu-heng Construction and identification of mouse RelB siRNA-expressing lentiviral vectors. Sci. Res. Essays 2011, 6:777-783.
26. Qiu T., Zhu H.C., Liu X.H., Dong W.C., Weng X.D., Hu C.H., Kuang Y.L., Gao R.H., Dan C., Tao T. Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells. Int. Immunopharmacol. 2012, 12:501-509.
27. Niimi M. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J. Heart Lung Transpl. 2001, 20:1123-1128.
28. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J. Heart Lung Transpl. 2005, 24:1710-1720.
29. Vlad G., Cortesini R., Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J. Immunol. 2005, 174:5907-5914.
30. van Kooten C., Lombardi G., Gelderman K.A., Sagoo P., Buckland M., Lechler R., et al. Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation 2011, 91:2-7.
31. Lou Y., Seipp R., Cai B., Chen S., Vitalis T., Choi K., et al. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1. Vaccine 2007, 25:2331-2339.
32. Tiao M.M., Lu L., Tao R., Wang L., Fung J.J., Qian S. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann. Surg. 2005, 241:497-505.
33. Isomura I., Tsujimura K., Morita A. Antigen-specific peripheral tolerance induced by topical application of NF-kappaB decoy oligodeoxynucleotide. J. Invest. Dermatol. 2006, 126:97-104.
34. Darrasse-Jeze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009, 206:1853-1862.
35. Shalev I., Schmelzle M., Robson S.C., Levy G. Making sense of regulatory T cell suppressive function. Semin. Immunol. 2011, 23:282-292.
36. Li X., Dou K.F., Liu H.L., et al. Immune tolerance induced by IL-10 and methylprednisolone modified dendritic cells in vitro. Chin. J. Cell Mol. Immunol. 2007, 23:436-438.
37. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.